James H. Bloem Retires From Genesis HealthCare Board of Directors

Rhea-AI Summary

Genesis Healthcare, Inc. (GENN) announced the retirement of James H. Bloem from its Board of Directors, effective January 31, 2022. Bloem had two terms on the board, first from 2001-2003 and later from 2015 until his retirement. The Executive Chairman, David Harrington, expressed gratitude for Bloem's over ten years of service, noting his dedication to guiding the company through various changes. Genesis operates over 250 skilled nursing facilities and provides post-acute care and rehabilitation therapy across the U.S., emphasizing a universal COVID-19 vaccine requirement for staff.

Positive

• James H. Bloem's retirement could usher in new leadership perspectives.
• Genesis operates a significant network of over 250 skilled nursing facilities, indicating a robust market presence.

Negative

• The retirement of a long-serving director may create concerns about continuity in leadership.
• Potential experience gaps in the board following Bloem's departure could impact strategic decisions.

KENNETT SQUARE, Pa., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (OTC: GENN), a national post-acute care provider, announced today that effective January 31, 2022, James H. Bloem retired from the Genesis Board of Directors.

Mr. Bloem served two tenures as a Genesis Director. The first term was from 2001-2003. The second term was from 2015, when the Company re-emerged as a public company, to the present.

“The Board and I would like to thank Jim who has worked tirelessly for more than a decade to guide and support Genesis through its many evolutions,” said David Harrington, Executive Chairman of the Board for Genesis. “We are appreciative of Jim’s unwavering commitment and dedication to our organization and we wish him much success in his next chapter.”

“It has been an honor and privilege to serve the various constituencies of the company, especially its residents and patients who are among the most vulnerable members of our society and its employees who are highly dedicated professionals,” said Mr. Bloem.

About Genesis HealthCare
Genesis Healthcare, Inc. is a holding company with subsidiaries that, on a combined basis, offer services to more than 250 skilled nursing facilities and assisted/senior living communities in 22 states nationwide. Genesis affiliates provide high-quality post-acute care, long-term care and assisted/senior living services in the local markets in which they serve. All facilities follow a universal staff COVID-19 vaccine requirement to protect patients, residents, families and fellow colleagues. Genesis subsidiaries also supply rehabilitation therapy to approximately 1,100 healthcare providers in 43 states and the District of Columbia. References made in this release to "Genesis," "the Company," "we," "us" and "our" refer to Genesis Healthcare, Inc. and each of its wholly-owned companies. Visit our website at www.genesishcc.com.

Contact:	Lori Mayer
	610-283-4995

FAQ

Who retired from the Genesis Board of Directors on January 31, 2022?

James H. Bloem retired from the Genesis Board of Directors.

What was the tenure of James H. Bloem on the Genesis Board?

James H. Bloem served two terms: first from 2001-2003 and then from 2015 until his retirement.

What is the impact of James H. Bloem's retirement on Genesis?

His retirement may bring fresh leadership perspectives but could also raise concerns regarding continuity and experience on the board.

What services does Genesis Healthcare, Inc. provide?

Genesis offers post-acute care and rehabilitation therapy through over 250 skilled nursing facilities across the U.S.